«Hallucinations

Below is an extended Hallucinations patents listing. Click here to return to the Hallucinations main in depth entry.

Patents :
US Patent No.	Title
7368531	Human secreted proteins
7390816	Methods for treating urinary incontinence in patients suffering from memory disorders
7393537	Botulinum toxin for treatment of obsessive compulsive finger biting disorder
7393538	Clostridial toxin treatment for dermatillomania
7393934	Human G-protein chemokine receptor (CCR5) HDGNR10
7396535	Therapy for obsessive compulsive head banging
7396654	Neural proteins as biomarkers for traumatic brain injury
7399861	Soft anticholinergic esters
7400927	Method and system for psychological treatment by brain stimulation of the psychologically disordered object
7402564	Synthetic peptide amides
7402590	Spiroazacyclic compounds as monoamine receptor modulators
7390637	Keratinocyte derived interferon
7390496	Therapeutic treatments for repetitive hand washing
7388023	Amino acids with affinity for the .alpha.2.delta.-protein
7371778	Spiro and dispiro 1,2,4-trioxolane antimalarials
7371811	Schizophrenia associated genes, proteins and biallelic markers
7375136	pH-dependent NMDA receptor antagonists
7375226	Bi- and tricyclic substituted phenyl methanones
7378410	Substituted lactams and their use as anti-cancer agents
7378434	Metaxalone products, method of manufacture, and method of use
7378496	hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target
7381721	Substituted piperidine compounds
7381800	Antibodies to HBIMF63 polypeptide
7384934	Piperazine substituted aryl benzodiazepines
7402592	Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders
7402652	Baclofen conjugate and a pharmaceutical composition for treatment of neuronal disorders
7423054	Therapeutic pyrazolo[3,4-b]pyridines and indazoles
7425340	Permeation enhancing compositions for anticholinergic agents
7425420	Identification of ligands by selective amplification of cells transfected with a 5HT2A receptor
7425614	Neuroprotective therapeutics preventing ERK/MAPK activation through the NMDA receptor
7427485	Method for classification of anti-psychotic drugs
7427612	Benzoyl-piperazine derivatives
7428323	Method and system for automatic diagnosis of possible brain disease
7429238	Systems and methods for the generation of crystalline polymorphs
7429585	Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups
7432376	Tropane prodrugs with central nervous system activity
7422753	Methods for treating trichotillomania
7420043	Reagents for detecting efavirenz
7419816	Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
7402687	Dihydrobenzofuran derivatives and uses thereof
7404489	Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
7407966	Thienopyridinone compounds and methods of treatment
7409321	Method and system for analyzing multi-variate data using canonical decomposition
7410759	Compositions and methods for diagnosing and treating mood disorders
7411051	Antibodies to HDPPA04 polypeptide
7411069	Doxepin analogs and methods of use thereof
7417043	Modulators of dopamine neurotransmission
7417147	Soft anticholinergic zwitterions
7419686	Opioid agonist/antagonist combinations
7433482	Microphone in a cylindrical housing having elliptical end faces

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.